InvestorsHub Logo
Followers 19
Posts 671
Boards Moderated 0
Alias Born 11/16/2016

Re: None

Friday, 08/11/2017 3:18:16 PM

Friday, August 11, 2017 3:18:16 PM

Post# of 64411
The only news that matters is the start of clinical trials. None of this new book nonsense. It will bounce on technical but that will fade quickly because the dilution is incessant. Literally a billion shares can still be converted, it's such a terrible financial situation. The fact that the company didn't try to negotiate with the note holders to reduce or postpone conversions and hasn't been public about easing investor confidence tells you that they are planning on more toxic financing.

Great idea and company concept, but absolutely atrocious execution. CEO claims this is a .03+ stock but has done nothing yet to justify that and has no respect for shareholders. Also ignoring all investor emails is a very ugly representation of his commitment to investors. Another CEO with big words with no action behind them.